并行传输
化学
胶体金
跨细胞
跨细胞
吸收(声学)
全身循环
聚乙二醇化
肠上皮
粘液
淋巴系统
生物物理学
淋巴
纳米颗粒
管腔(解剖学)
微熔池
细胞生物学
上皮
口服
紧密连接
肠粘膜
淋巴结
胃肠上皮
全身给药
上皮极性
碳酸钙-2
作者
Di Huang,Jiahao Tang,Dongmiao Sang,Caiming Luo,Yue Tan,Jinbin Liu
出处
期刊:Nano Letters
[American Chemical Society]
日期:2026-10-05
卷期号:26 (41): 14193-14201
标识
DOI:10.1021/acs.nanolett.6c03273
摘要
The intestinal epithelial barrier severely impedes absorption of orally administered nanoparticles. Herein, we designed ultrasmall PEPT1-targeted gold nanoparticles (GP-AuNPs) using a dual-ligand strategy: Gly-Sar peptides for PEPT1 recognition on intestinal epithelial cells and PEGylation to improve stability and mucus penetration. Orally administered GP-AuNPs efficiently cross the intestinal mucus barrier, undergo specific PEPT1-mediated transcellular absorption in absorptive enterocytes and the follicle-associated epithelium of Peyer's patches, and enter systemic circulation mainly through the intestine-mesenteric lymph node pathway. Consequently, GP-AuNPs exhibit 41.9-fold higher oral absorption than untargeted PEGylated AuNPs. Importantly, this nanoparticle transport pathway differs from the conventional goblet cell-associated antigen passage pathway for antigen translocation across the intestinal epithelium, as goblet cell uptake does not deliver nanoparticles to the basal side but secretes them back into the lumen with mucus. These findings unravel the PEPT1-mediated oral absorption mechanism of nanoparticles and provide a promising strategy to enhance oral delivery efficiency of nanomedicines.
科研通智能强力驱动
Strongly Powered by AbleSci AI